Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 41 of the 42 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
OBJECTIVE—The effectiveness of intentional weight loss in reducing cardiovascular disease (CVD) events in type 2 diabetes is unknown. This report describes 1-year changes in CVD risk factors in a trial designed to examine the long-term effects of an intensive lifestyle intervention on the incidence of major CVD events. RESEARCH DESIGN AND METHODS—This study consisted of a multicentered, randomized, controlled trial of 5,145 individuals with type 2 diabetes, aged 45–74 years, with BMI >25 kg/m2 (>27 kg/m2 if taking insulin). An intensive lifestyle intervention (ILI) involving group and individual meetings to achieve and maintain weight loss through decreased caloric intake and increased physical activity was compared with a diabetes support and education (DSE) condition. RESULTS—Participants assigned to ILI lost an average 8.6% of their initial weight vs. 0.7% in DSE group (P < 0.001). Mean fitness increased in ILI by 20.9 vs. 5.8% in DSE (P < 0.001). A greater proportion of ILI participants had reductions in diabetes, hypertension, and lipid-lowering medicines. Mean A1C dropped from 7.3 to 6.6% in ILI (P < 0.001) vs. from 7.3 to 7.2% in DSE. Systolic and diastolic pressure, triglycerides, HDL cholesterol, and urine albumin-to-creatinine ratio improved significantly more in ILI than DSE participants (all P < 0.01). CONCLUSIONS—At 1 year, ILI resulted in clinically significant weight loss in people with type 2 diabetes. This was associated with improved diabetes control and CVD risk factors and reduced medicine use in ILI versus DSE. Continued intervention and follow-up will determine whether these changes are maintained and will reduce CVD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight-loss specific behaviors associated with long term success include: frequent self-monitoring and self-weighing, reduced calorie intake, smaller and more frequent meals/snacks throughout the day, increased physical activity, consistently eating breakfast, more frequent at-home meals compared with restaurant and fast-food meals, reducing screen time, and use of portion-controlled meals or meal”
From Maintenance of Lost Weight and Long-Term Management of Obesity (2018) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regarding whole foods, multiple meal patterns have been shown to be advantageous for the management of DM, which promote reductions in glycemia, BP, and CVD risk factors.679,901,920–924”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [922]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“previously studied interventions elicited 4–9% weight loss in patients with T2D [25, 26]”
From Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HbA1c reductions up to 7 mmol mol−1 (0.6%) via intensive lifestyle intervention [25] and 11 mmol mol−1 (1.0%) via an energy-restricted low-carbohydrate diet with partial food provision delivered via an outpatient setting [26] were previously reported.”
From Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the Look AHEAD (Action for Health in Diabetes) study, intensive lifestyle participants exhibited greater decreases in triglycerides and increases in HDL cholesterol than the control group, while both the intensive lifestyle and usual care groups decreased LDL cholesterol ( 218 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [218]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Cited by
Items 301–400 of 1,000
Rock, C. L., Flatt, S. W., Pakiz, B., Quintana, E. L., Heath, D. D., Rana, B. K., & Natarajan, L. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.008 · Cited by 76
“Study participants in each of the study arms (lower fat, lower carbohydrate, and walnut-rich diet) demonstrated significant weight loss at 12 months, and the overall degree of weight reduction achieved (~8% of initial weight) has been shown to reduce risk of diabetes and cardiovascular disease risk factors in previous…”
Bayliss, J. A., Lemus, M. B., Santos, V. V., Deo, M., Davies, J. S., Kemp, B. E., Elsworth, J. D., & Andrews, Z. B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159381 · Cited by 75
“Indeed, in a human study patients with T2D with Metformin monotherapy had a longer survival than matched non-diabetic controls [11].”
BackgroundInfluentialNeiberg, R. H., Wing, R. R., Bray, G. A., Reboussin, D. M., Rickman, A. D., Johnson, K. C., Kitabchi, A. E., Faulconbridge, L. F., Kitzman, D. W., Espeland, M. A., et al. (2012) · Obesity · doi:10.1038/oby.2012.33 · Cited by 77
Fabricatore, A. N., Wadden, T. A., Ebbeling, C. B., Thomas, J. G., Stallings, V. A., Schwartz, S., & Ludwig, D. S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.016 · Cited by 75
Qian, J., Walkup, M. P., Chen, S., Brubaker, P. H., Bond, D. S., Richey, P. A., Jakicic, J. M., Hu, K., Scheer, F. A. J. L., & Middelbeek, R. J. W. (2021) · Diabetes Care · doi:10.2337/dc20-2178 · Cited by 80
Improving Weight Loss Outcomes of Community Interventions by Incorporating Behavioral Strategies
Wing, R. R., Crane, M. M., Thomas, J. G., Kumar, R., & Weinberg, B. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.183616 · Cited by 74
Cognitive and Behavioral Approaches in the Treatment of Obesity
Dorsten, B. V., & Lindley, E. M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.008 · Cited by 87
Obesity and Diabetes: The Impact of Bariatric Surgery on Type‐2 Diabetes
Dixon, J. B. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0062-y · Cited by 89
“Recently, the early results from the intensive lifestyles intervention arm of the US ‘‘Look Ahead’’ study demonstrated improved glycemic control and reduced cardiovascular risk associated with weight loss [27].”
BackgroundCox, M. E., Yancy, W. S., Coffman, C. J., Østbye, T., Tulsky, J. A., Alexander, S. C., Brouwer, R. J. N., Dolor, R. J., & Pollak, K. I. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.01.024 · Cited by 74
“Introduction Overweight and obese patients who increase physical activity, eat healthier, and lose weight achieve improved health outcomes (1-3).”
BackgroundMethodWang, J., Cai, C., Padhye, N., Orlander, P., & Zare, M. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.4478 · Cited by 72
Blonde, L., Stenlöf, K., Fung, A., Xie, J., Canovatchel, W., & Meininger, G. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1169894 · Cited by 71
“6%) [28] and some other weight-loss agents, like phentermine/topiramate (–5.”
BackgroundHealth Economic Evaluation of Type 2 Diabetes Mellitus: A Clinical Practice Focused Review
Liebl, A., Khunti, K., Orozco-Beltran, D., & Yale, J.-F. (2015) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.4137/cmed.s20906 · Cited by 67
Westerveld, D., & Yang, D. (2016) · Surgery Research and Practice · doi:10.1155/2016/8616581 · Cited by 67
Potential Benefits of Weight Loss in Coronary Heart Disease
Ades, P. A., & Savage, P. D. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.09.009 · Cited by 78
Blonde, L., Pencek, R., & MacConell, L. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0171-2 · Cited by 72
Apovian, C. M., Garvey, W. T., & Ryan, D. H. (2015) · Obesity · doi:10.1002/oby.21140 · Cited by 72
“In the first year of the Look AHEAD study, 68% of participants experienced 5% weight loss, 55% reached >7% weight loss, and 38% of participants lost 10% of their initial body weight (66,67).”
BackgroundSubclinical Myocardial Impairment in Metabolic Diseases
Kosmala, W., Sanders, P., & Marwick, T. H. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.04.001 · Cited by 77
Iijima, H., Kifuji, T., Maruyama, N., & Inagaki, N. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0234-0 · Cited by 70
“In addition to blood glucose control, the management of body weight and blood pressure is critical for the prevention of diabetic complications [7, 8].”
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men
Corona, G., Bianchini, S., Sforza, A., Vignozzi, L., & Maggi, M. (2015) · HORMONES · doi:10.14310/horm.2002.1635 · Cited by 74
Cost-Effectiveness of Lifestyle Modification in Diabetic Patients
Jacobs-van der Bruggen, M. A. M., van Baal, P. H., Hoogenveen, R. T., Feenstra, T. L., Briggs, A. H., Lawson, K., Feskens, E. J. M., & Baan, C. A. (2009) · Diabetes Care · doi:10.2337/dc09-0363 · Cited by 69
“• Look AHEAD: a one-year intensive lifestyle intervention for overweight patients (n=5145) evaluated at 12 months (15)”
BackgroundMethodPatel, K. V., Bahnson, J. L., Gaussoin, S. A., Johnson, K. C., Pi-Sunyer, X., White, U., Olson, K. L., Bertoni, A. G., Kitzman, D. W., Berry, J. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050941 · Cited by 69
Viester, L., Verhagen, E. A. L. M., Bongers, P. M., & van der Beek, A. J. (2017) · American Journal of Health Promotion · doi:10.1177/0890117117694450 · Cited by 80
Body–Brain Connections: The Effects of Obesity and Behavioral Interventions on Neurocognitive Aging
Stillman, C. M., Weinstein, A. M., Marsland, A. L., Gianaros, P. J., & Erickson, K. I. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00115 · Cited by 64
“Regular PA confers protection against cardiovascular disease, Type 2 diabetes mellitus, and hypertension (e.g., Espeland, 2007; Jackson et al., 2014; SoaresMiranda et al., 2016).”
BackgroundThe 2012 SEMDSA Guideline for the Management of Type 2 Diabetes
Amod, A. (2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872276 · Cited by 76
CHILTON, R. J., Wyatt, J., Nandish, S., OLIVEROS, R. A., & Lujan, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.004 · Cited by 73
Principles and Practice of Nonpharmacological Interventions to Reduce Cardiometabolic Risk
Dagogo-Jack, S. E., Egbuonu, N., & Edeoga, C. (2010) · Medical Principles and Practice · doi:10.1159/000285280 · Cited by 71
Results that matter: Structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes
Parkin, C. G., Buskirk, A., Hinnen, D. A., & Schweitzer, M. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.03.002 · Cited by 71
Glucose challenge test screening for prediabetes and undiagnosed diabetes
Phillips, L. S., Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Chatterjee, R., Narayan, K. M. V., & Koch, D. D. (2009) · Diabetologia · doi:10.1007/s00125-009-1407-7 · Cited by 67
“In contrast, detection earlier in the natural history at the stage of prediabetes can enable lifestyle change and/or use of pharmacological agents to keep glucose levels near-normal, prevent or delay the development of diabetes, and improve other CVD risk factors [9, 10].”
Metabolic Syndrome and Cardiometabolic Risk Factors
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 68
Kempf, K., Kruse, J., & Martin, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0008 · Cited by 66
“Also, unstructured advice for lifestyle change, which did not lead to higher weight loss, was not effective in significantly improving HbA1c in a group of intensive SMBG performers compared to individuals who rarely performed SMBG. 18 Furthermore, our measurements were based on self-reports, and clinical parameters wer…”
InfluentialPromrat, K., Longato, L., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00815.x · Cited by 66
White, G. E., Shu, I., Rometo, D., Arnold, J., Korytkowski, M., & Luo, J. (2023) · Obesity · doi:10.1002/oby.23622 · Cited by 66
Espeland, M. A., Rejeski, W. J., West, D. S., Bray, G. A., Clark, J. M., Peters, A. L., Chen, H., Johnson, K. C., Horton, E. S., Hazuda, H. P., et al. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12271 · Cited by 66
The Changing Landscape of Nutrition in Cystic Fibrosis: The Emergence of Overweight and Obesity
Bailey, J., Krick, S., & Fontaine, K. R. (2022) · Nutrients · doi:10.3390/nu14061216 · Cited by 73
Ectopic fat deposition and global cardiometabolic risk: New paradigm in cardiovascular medicine
Shimabukuro, M., Kozuka, C., Taira, S.-I., Yabiku, K., Dagvasumberel, M., Ishida, M., Matsumoto, S., Yagi, S., Fukuda, D., Yamakawa, K., et al. (2013) · The Journal of Medical Investigation · doi:10.2152/jmi.60.1 · Cited by 66
Novel therapeutics for type 2 diabetes: insulin resistance
Altaf, Q. A., Barnett, A. H., & Tahrani, A. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12400 · Cited by 75
Mcgavock, J., Sellers, E., & Dean, H. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.057 · Cited by 65
“Prospective cohort studies or randomised controlled trials of specific lifestyle strategies are required to confirm the effectiveness of these interventions in youth with T2DM.”
BackgroundResultInfluentialActivity Patterns of Obese Adults with Type 2 Diabetes in the Look AHEAD Study
JAKICIC, J. M., GREGG, E., KNOWLER, W., KELLEY, D. E., LANG, W., MILLER, G. D., PI-SUNYER, F. X., REGENSTEINER, J. G., REJESKI, W. J., RIBISL, P., et al. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e054f0 · Cited by 65
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 4 Self-reported leisure-time physical activity (LTPA) by categories of BMI, sex, race/ethnicity, age, fitness, diabetes treatment, and cardiovascular disease history.”
MethodDavison, K. A. K., Negrato, C. A., Cobas, R. A., Matheus, A. S. D. M., Tannus, L. R. M., Palma, C. C. S., Japiassú, L., Carneiro, J. R. I., Rodacki, M., Zajdenverg, L., et al. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-19 · Cited by 77
Sun, J., Wang, Y., Chen, X., Chen, Y., Feng, Y., Zhang, X., Pan, Y., Hu, T., Xu, J., Lu-yuan, D., et al. (2008) · PubMed · Cited by 74
Exercise: the brittle cornerstone of type 2 diabetes treatment
Praet, S. F. E., & van Loon, L. J. C. (2008) · Diabetologia · doi:10.1007/s00125-007-0910-y · Cited by 62
“Although the longterm outcome of such an approach is currently being investigated in a large-scale prospective study on intensive lifestyle interventions, the preliminary results look promising [9].”
BackgroundBentley‐Edwards, K. L., Carr, L. T. B., Robbins, P. A., Conde, E., Zaw, K., & Darity, W. A. J. (2019) · Journal of Religion and Health · doi:10.1007/s10943-019-00888-6 · Cited by 65
Behavioral Treatment of the Patient with Obesity
Alamuddin, N., & Wadden, T. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.008 · Cited by 65
“7% in the DSE group.(46) The ILI group was superior to DSE in improvements in BP, blood glucose, HbA1c, fitness, quality of life, physical function, sleep apnea, and other outcomes.”
MethodShamanna, P., Erukulapati, R. S., Shukla, A., Shah, L., Willis, B., Thajudeen, M., KOVIL, R. R., Baxi, R., Wali, M., Damodharan, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76584-7 · Cited by 72
“4), demonstrating the DT Program’s potential to significantly reduce or eliminate medication use in a large proportion of participants.”
BackgroundSimpson, S. A., McNamara, R., Shaw, C., Kelson, M., Moriarty, Y., Randell, E., Cohen, D., Alam, M. F., Copeland, L., Duncan, D., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19500 · Cited by 58
Nutrition and the science of disease prevention: a systems approach to support metabolic health
Bennett, B. J., Hall, K. D., Hu, F. B., McCartney, A. L., & Roberto, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12945 · Cited by 71
Andary, R., Fan, W., & Wong, N. D. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.05.035 · Cited by 62
Does home-based exercise improve body mass index in patients with type 2 diabetes?
Krousel-Wood, M. A., Berger, L., Jiang, X., Blonde, L., Myers, L., & Webber, L. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.028 · Cited by 62
Obesity treatment in disadvantaged population groups: Where do we stand and what can we do?
Harvey, J. R., & Ogden, D. E. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.05.015 · Cited by 57
Management of Glycemia in Patients With Diabetes Mellitus and CKD
Lubowsky, N. D., Siegel, R. D., & Pittas, A. G. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.08.012 · Cited by 68
Belalcazar, L. M., Haffner, S. M., Lang, W., Hoogeveen, R. C., Rushing, J., Schwenke, D. C., Tracy, R. P., Pi‐Sunyer, F. X., Kriska, A. M., & Ballantyne and the Look AHEAD (Action for Health in Diabetes, C. M. (2013) · Obesity · doi:10.1002/oby.20431 · Cited by 63
“Procedures for obtaining anthropometric measures, hemoglobin A1c (HbA1c), glucose and lipids in Look AHEAD have been previously described (26).”
MethodPhelan, S., Jankovitz, K., Hagobian, T. A., & Abrams, B. F. (2011) · Women s Health · doi:10.2217/whe.11.70 · Cited by 67
“Also of note is that even with comprehensive behavioral weight loss programs, gradual weight regain is often observed over time, resulting in modest (~5%) overall weight losses at 3–4 years [21,25].”
BackgroundResultShort‐term weight loss with diet and physical activity in young adults: The IDEA study
Jakicic, J. M., King, W. C., Marcus, M. D., Davis, K. K., Helsel, D., Rickman, A. D., Gibbs, B. B., Rogers, R. J., Wahed, A., & Belle, S. H. (2015) · Obesity · doi:10.1002/oby.21241 · Cited by 60
“The majority of these interventions have been implemented in middle-age or older adults (4-13).”
BackgroundBoutelle, K. N., Manzano, M. A., & Eichen, D. M. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113018 · Cited by 61
Obesity and sedentary lifestyles: risk for cardiovascular disease in women.
Barnes, A. S. (2012) · Europe PMC (PubMed Central) · Cited by 96
Ye, Z., Chen, L., Yang, Z. H., Li, Q., Huang, Y., He, M., Zhang, S., Zhang, Z., Wang, X., Zhao, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021551 · Cited by 69
“glucose metabolism and increased insulin sensitivity [6,14,15,16].”
Dodevska, M. S., Sobajic, S. S., Djordjević, P., Dimitrijevic-Sreckovic, V. S., Spasojević‐Kalimanovska, V., & Djordjevic, B. I. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0831-3 · Cited by 70
“Differences in examined parameters before and after dietary interventions were analysed by analysis of covariance (ANCOVA) with an adjustment for other variables (body weight, waist circumference, HDL-cholesterol, total energy and carbohydrate intake).”
BackgroundInfluentialOverweight and obesity: The pathogenesis of cardiometabolic risk
Bray, G. A., Clearfield, M. B., Fintel, D. J., & Nelinson, D. S. (2009) · Clinical cornerstone · doi:10.1016/s1098-3597(09)80003-3 · Cited by 76
Di Prospero, N. A., Yee, J., Frustaci, M. E., Samtani, M. N., Alba, M., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12433 · Cited by 60
“Weight loss through dietary intervention (or pharmacotherapy) in individuals with T2DM results in rapid reductions in FPG, HbA1c and fasting insulin.(36-39) In addition, previous studies have demonstrated that patients who have experienced a 5%–10% reduction in body weight also display a 0.”
BackgroundBoutelle, K. N., Knatz, S., Carlson, J., Bergmann, K., & Peterson, C. B. (2017) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2016.08.003 · Cited by 60
“On the other hand, behavioral weight loss (BWL) is an efficacious treatment for overweight and obese adults (Diabetes Prevention Program Research Group, 2002; Espeland, 2007; Wadden, Butryn, & Wilson, 2007).”
BackgroundSailer, P., Wieber, F., Pröpster, K., Stoewer, S., Nischk, D., Volk, F., & Odenwald, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0513-y · Cited by 60
“These rates resemble those observed in other trials, such as the Diabetes Prevention Program (DPP; [35]), in which 74 % of individuals with impaired glucose tolerance met the goal of at least 150 min of physical activity per week after 24 weeks, and the Look AHEAD trial [37], in which overweight or obese patients with…”
ResultHall, P. A., Fong, G. T., & CHENG, A. Y. Y. (2011) · Journal of Behavioral Medicine · doi:10.1007/s10865-011-9389-6 · Cited by 67
Cugusi, L., Dessalvi, C. C., Nocco, S., Fabio, O., Bandino, S., Deidda, M., Caria, A., Bassareo, P. P., Piras, A., Cabras, S., et al. (2014) · PM&R · doi:10.1016/j.pmrj.2014.09.004 · Cited by 66
“Our data are in line with previous observational studies that have shown that both aerobic and resistance exercise can reduce blood pressure levels in diabetic subjects, especially when in association with a significant reduction of body weight, as was found in our study [3,30,31].”
BackgroundResultGallagher, D., Heshka, S., Kelley, D. E., Thornton, J., Boxt, L., Pi-Sunyer, F. X., Patricio, J., Mancino, J., Clark, J. M., & the MRI Ancillary Study Group of the Look AHEAD Research Group (2014) · Diabetes Care · doi:10.2337/dc14-1585 · Cited by 59
Self-citationAzar, K. M. J., Aurora, M., Wang, E. J., Muzaffar, A., Pressman, A., & Palaniappan, L. P. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-014-0296-6 · Cited by 59
Höchsmann, C., Dorling, J. L., Martin, C. K., Newton, R. L., Apolzan, J. W., Myers, C. A., Denstel, K. D., Mire, E. F., Johnson, W. D., Zhang, D., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051328 · Cited by 54
Polycystic Ovary Syndrome: A Common Endocrine Disorder and Risk Factor for Vascular Disease
McGowan, M. P. (2011) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-011-0130-0 · Cited by 68
Fasting as possible complementary approach for polycystic ovary syndrome: Hope or hype?
Chiofalo, B., Laganà, A. S., Palmara, V. I., Granese, R., Corrado, G., Mancini, E., Vitale, S. G., Frangež, H. B., Bokal, E. V., & Triolo, O. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.013 · Cited by 64
Reeves, M., Winkler, E., Mccarthy, N., Lawler, S., Terranova, C., Hayes, S., Janda, M., Demark-Wahnefried, W., & Eakin, E. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12629 · Cited by 58
Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s365416 · Cited by 58
Gallwitz, B., Vaag, A., Falahati, A., & Madsbad, S. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02265.x · Cited by 58
Defries, D. M., Taylor, C. G., Appah, P., Blewett, H., & Zahradka, P. C. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.021 · Cited by 62
Vergès, B., Bonnard, C., & Renard, E. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.07.001 · Cited by 58
The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised)
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872287 · Cited by 69
Huberty, V., Boškoski, I., Bove, V., Ouytsel, P. V., Costamagna, G., Barthet, M. A., & Deviere, J. M. E. (2020) · Gut · doi:10.1136/gutjnl-2020-322026 · Cited by 64
Moscatiello, S., Di Luzio, R., Bugianesi, E., Suppini, A., Hickman, I. J., Di Domizio, S., Dalle Grave, R., & Marchesini, G. (2011) · Obesity · doi:10.1038/oby.2010.254 · Cited by 57
The use of motivational interviewing in weight loss
Dorsten, B. V. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0063-x · Cited by 68
Ellrott, T. (2008) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-2007-986398 · Cited by 58
Figueira, F. R., Umpierre, D., Cureau, F. V., Zucatti, A. T. N., Dalzochio, M. B., Leitão, C. B., & Schaan, B. D. (2014) · Sports Medicine · doi:10.1007/s40279-014-0226-2 · Cited by 57
“These are well known benefits of lifestyle changes when physical activity is included in the daily habits of patients with diabetes [13, 17, 35, 36].”
BackgroundBenefits of moderate weight loss in patients with type 2 diabetes
Fujioka, K. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01155.x · Cited by 57
“A 1-year interim analysis [46] (table 1) reported that participants in the intensive lifestyle intervention group lost an average 8.”
MethodClifton, P. M. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1283 · Cited by 80
FTO predicts weight regain in the Look AHEAD clinical trial
AHEAD, T. G. S. O. L., McCaffery, J. M., The Look AHEAD Research Group, Papandonatos, G. D., Huggins, G. S., Peter, I., Kahn, S. E., Knowler, W. C., Hudnall, G. E., Lipkin, E. W., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.54 · Cited by 55
Dapagliflozin‐induced weight loss affects 24‐week glycated haemoglobin and blood pressure levels
Sjöström, C. D., Hashemi, M., Sugg, J., Ptaszynska, A., & Johnsson, E. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12500 · Cited by 56
“Given differences in populations, study length and treatment methods, the magnitude of the relationship between weight change and changes in risk factors in these analyses seems to match results from other studies with weight loss drugs [13] or lifestyle interventions [14].”
ResultRole of High‐Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control
Manandhar, B., Cochran, B. J., & Rye, K. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013531 · Cited by 59
“glycemic control, reduce the use of antidiabetic medications, and increase HDL levels.(113) While such interventions”
BackgroundImproving diabetes outcomes through lifestyle change—a randomized controlled trial
Delahanty, L. M., Dalton, K. M., Porneala, B., Chang, Y., Goldman, V. M., Levy, D., Nathan, D. M., & Wexler, D. J. (2015) · Obesity · doi:10.1002/oby.21172 · Cited by 55
“2% at 6 months, despite lower resource use (19 weekly sessions compared with 19 group and 6 individual sessions) and enrollment of a more clinically severe population (20,21).”
BackgroundAdolescent Obesity, Change in Weight Status, and Hypertension: Racial/Ethnic Variations
Suglia, S. F., Clark, C. J., & Gary-Webb, T. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00214 · Cited by 55
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., Davidson, M., EINHORN, D. F., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep151063.cs · Cited by 55
Plodkowski, R. A., Nguyen, Q., Sundaram, U., Nguyen, L. D., Chau, D., & Jeor, S. S. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902775750 · Cited by 60
Wilson, D. K., Kitzman, H. E., Resnicow, K., Horn, M. L. V., George, S. M. S., Siceloff, E. R., Alia, K. A., McDaniel, T. C., Heatley, V., Huffman, L. E., et al. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.03.009 · Cited by 59
The Potential of Virtual Reality Technologies to Improve Adherence to Weight Loss Behaviors
Coons, M. J., Roehrig, M., & Spring, B. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500221 · Cited by 53
Kauhl, B., Schweikart, J., Krafft, T., Keste, A., & Moskwyn, M. (2016) · International Journal of Health Geographics · doi:10.1186/s12942-016-0068-2 · Cited by 59
“Despite behavioral risk factors such as lack of physical exercise, dietary deficits and smoking [13], a wide range of studies additionally highlights an association between age, lower socioeconomic status and T2DM [4, 14–16].”
BackgroundPharmacological and non-pharmacological interventions to influence adipose tissue function
Westerink, J., & Visseren, F. L. J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-13 · Cited by 60
“[17-19].”
BackgroundKosmala, W., O'Moore‐Sullivan, T. M., Płaksej, R., Przewlocka-Kosmala, M., & Marwick, T. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1507-4 · Cited by 61
Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes
Baker, S., Jerums, G., & Proietto, J. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.06.002 · Cited by 59
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
Henry, R. R., Chilton, R., & Garvey, W. T. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.011 · Cited by 53
Greater weight loss with increasing age in the weight loss maintenance trial
Svetkey, L. P., Clark, J. M., Funk, K., Corsino, L., Batch, B. C., Hollis, J. F., Appel, L. J., Brantley, P. J., Loria, C. M., Champagne, C. M., et al. (2014) · Obesity · doi:10.1002/oby.20506 · Cited by 53
Catley, D., Puoane, T. R., Tsolekile, L. P., Resnicow, K., Fleming, K., Hurley, E. A., Smyth, J. M., Materia, F. T., Lambert, E. V., Vitolins, M. Z., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003964 · Cited by 57
“Randomized trials have demonstrated powerful clinical effects in preventing the development of T2DM [8,9] as well as reducing weight and improving glucose control, blood pressure, triglycerides, and high-density lipoprotein (HDL) cholesterol among individuals with T2DM [10].”
BackgroundInfluentialFour-year physical activity levels among intervention participants with type 2 diabetes
UNICK, J. L., GAUSSOIN, S. A., HILL, J. O., JAKICIC, J. M., BOND, D. S., HELLGREN, M., JOHNSON, K. C., PETERS, A. L., CODAY, M., KITZMAN, D. W., et al. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001054 · Cited by 52
Qian, J., Xiao, Q., Walkup, M. P., Coday, M., Erickson, M. L., Unick, J. L., Jakicic, J. M., Hu, K., Scheer, F. A. J. L., & Middelbeek, R. J. W. (2023) · Diabetes Care · doi:10.2337/dc22-2413 · Cited by 56
Sarma, A. V., Kanaya, A. M., Nyberg, L. M., Kusek, J. W., Vittinghoff, E., Rutledge, B. N., Cleary, P. A., Gatcomb, P., & Brown, J. S. (2009) · Urology · doi:10.1016/j.urology.2008.11.009 · Cited by 52
Metadata
- Authors
- The Look AHEAD Research Group
- Affiliations
- Wake Forest University Health Sciences (US)
- Corresponding author
- The Look AHEAD Research Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 30
- Issue
- 6
- Pages
- 1374-1383
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2665929
- OpenAlex
- W1554005703
- Semantic Scholar
- 14760a9ef6a15771653d7c092ab651c008e76eaf
- Cited by
- 1,522
- References
- 41
- Citations by year
- 2026: 22 · 2025: 45 · 2024: 30 · 2023: 48 · 2022: 51 · 2021: 59 · 2020: 54 · 2019: 67 · 2018: 72 · 2017: 82 · 2016: 97 · 2015: 119 · 2014: 100 · 2013: 116 · 2012: 120
- FWCI
- 72.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p30dk046204-15)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-57171, DK 57136, DK57149, DK 57002, DK57182, DK56990, (DK 046204, DK57008, DK57177, DK 57078, DK57219, U01DK057149, DK-57178, U01DK057151, U01DK057135, U01DK057131, U01DK056990, DK-57135, U01DK057136, DK-56992, DK57154, U01DK057178, U01DK057182, U01DK057078, U01DK057154, U01DK057008, U01DK057171, DK57131, U01DK057002, U01DK057219, U01DK056992, U01DK057177, P30DK048520, P30DK040561, DK 57151, P30-DK046204)
- National Center for Research Resources (M01-RR-0021140, M01RR002719, M01RR000056, M01RR000051, M01RR001066, M01RR001346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- type 2 diabetes, weight loss, cardiovascular risk factors, intensive lifestyle intervention, diabetes support and education, glycemic control, HbA1c, physical activity, caloric restriction, hypertension, lipid-lowering drugs, albuminuria, medication reduction
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Exercise Test, Follow-Up Studies, Humans, Life Style, Middle Aged, Patient Education as Topic, Physical Fitness, Self Care, Time Factors, Weight Loss, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.